Literature DB >> 12925384

Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions.

Kenneth A Katz1, Chad M Hivnor, David E Geist, Michael Shapiro, Michael E Ming, Victoria P Werth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12925384     DOI： 10.1001/archderm.139.8.991

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  5 in total

Review 1.  Intravenous immunoglobulin: adverse effects and safe administration.

Authors:  Hedi Orbach; Uriel Katz; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 2.  Seeking approval: present and future therapies for pemphigus vulgaris.

Authors:  Xuming Mao; Aimee S Payne
Journal:  Curr Opin Investig Drugs       Date:  2008-05

3.  Treatment of pediatric optic neuritis.

Authors:  Gabrielle R Bonhomme; Ellen B Mitchell
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.972

Review 4.  On the dark side of therapies with immunoglobulin concentrates: the adverse events.

Authors:  Peter J Späth; Guido Granata; Fabiola La Marra; Taco W Kuijpers; Isabella Quinti
Journal:  Front Immunol       Date:  2015-02-05       Impact factor: 7.561

5.  Intravenous immunoglobulin in dermatology.

Authors:  Sandipan Dhar
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.